Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. (2025). Archives of Clinical and Biomedical Research, 9(6), 521-541. https://fortunejournals.org/ojs/index.php/acbr/article/view/15154